Dark Spot Corrector - 1% Synovea® HR

Phase
Product
INCI Name
Supplier
Volume
A
-
Water (demineralized)
qs
-
Disodium EDTA
0.10
Glycerine 99%
Glycerin
Ruger
3.00
Niacinamide PC
Niacinamide
DSM
2.00
-
Acetyl Glucosamine
1.00
Vanzan NF
Xanthan Gum
Vanderbilt
0.10
Carbopol Ultrez 21
Acrylates/C10-30 Alkyl Acrylate Copolymer
BF Goodrich
0.30
B
Myritol 318
Caprylic/Capric Triglycerides
Cognis
3.00
Lipovol J Clear
Jojoba Seed Oil
Lipo
2.00
Emulium 22
Tribehenin PEG-20 Esters
Gattefosse
2.50
Shebu Refined
Butyrospermum Parkii (Shea Butter)
Rita
2.00
Vitamin E Acetate
Tocopheryl Acetate
DSM
0.10
Arlacel 165
Glyceryl Stearate, PEG-100 Stearate
Croda
1.00
Crodacol C-70
Cetyl Alcohol
Croda
0.70
DC, 200/50CST
Dimethicone
Dow Corning
2.00
Synovea® DOI
Isosorbide Dicaprylate
Sytheon
2.00
C
Trolamine 99 (to pH 5.5)
Triethanolamine 99%
0.10
D
Sepigel 305
Polyacrylamide, C13-14 Isoparaffin, Laureth-4
Seppic
0.75
E
Butylene Glycol
Butylene Glycol
Ruger
2.00
Synovea® HR
Hexylresorcinol
Sytheon
1.00
F
Euxyl PE 9010
Phenoxyethanol, Ethylhexyglycerine
Schuelke
1.00
G
Frag. #K3258/
Fragrance
Carruba
0.20

Preparation:

Combine A-1; disperse A2 in A1 while stirring and heat A to 750C. Combine phase B ingredients then heat to 75 0C. Add phase B to A with good mixing. Homogenize mixture at high speed, while adding phase C & D. Cooling to 400C and slowly add pre-mixed phase E. Add phase F; stir gently until mixture is homogeneous and then add phase G.

Notes:

pH value: 5.4; Viscosity: 35,000-50,000 cps (Brookfield RVT, spindle C, Helipath) at 250 C
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.